Loading profile...
TruScreen CEO, Martin Dillon commented: "Adding South Africa is a major milestone in our African distribution strategy. The majority of African nations are emerging economies with limited or no screening laboratory infrastructure. The TruScreen technology will assist to reduce deaths from cervical cancer. TruScreen is also well suited to increase the screening rates in 47 WHO member nations looking to achieve 70% screening rates by 2030."
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.